Jaguar Uranium Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 12, 2026, reporting unaudited interim financial results and balance sheet data for the nine months ended September 30, 2026.

Key Highlights

  • Net loss of $22,133,780 for the nine months ended September 30, 2026, compared with a net loss of $1,497,050 for the same period in 2025, according to the filing.
  • Liquidity event and listing event shares charge of $17,747,028 and a liquidity event deferred cash payment of $720,700 were recognized in the nine-month period, the filing disclosed.
  • Total assets grew to $26,520,265 as of September 30, 2026, up from $8,369,411 as of December 31, 2025, driven primarily by cash of $8,421,807 and short-term investments of $9,758,015.
  • IPO net proceeds of $22,675,000 were raised on completion of the initial public offering, with shares outstanding increasing to 20,263,777 from 9,057,020 at December 31, 2025.
  • Basic and diluted loss per share was $(1.20) for the nine months ended September 30, 2026, versus $(0.17) for the same period in 2025.
  • No revenue was reported in any period presented; total operating expenses for the nine months ended September 30, 2026 were $3,917,118.

Jaguar Uranium's Financial Position Following NYSE American Listing

Jaguar Uranium Corp. (NYSE American:JAGU), a British Columbia-incorporated uranium exploration company, reported a net loss of $22,133,780 for the nine months ended September 30, 2026, according to the unaudited condensed consolidated interim financial statements included in the filing. The company generated no revenue in any of the periods presented. The outsized loss compared with $1,497,050 for the nine months ended September 30, 2025 was driven in large part by two non-operating charges: a liquidity event and listing event shares expense of $17,747,028 and a liquidity event deferred cash payment of $720,700, both recognized in the nine-month period ended September 30, 2026.

On the balance sheet, the company reported total assets of $26,520,265 as of September 30, 2026, against total liabilities of $2,146,048, leaving total shareholders' equity of $24,374,217. Cash and cash equivalents stood at $8,421,807, with an additional $9,758,015 in short-term investments, both of which were absent or negligible at December 31, 2025. Mineral properties remained carried at $8,150,000 in both periods. The convertible debentures balance of $150,000 at December 31, 2025 was reduced to zero by September 30, 2026, the filing showed.

Operating expenses for the nine months ended September 30, 2026 totaled $3,917,118, including general and administrative expenses of $2,597,725, exploration and evaluation expenditures of $636,342, legal and professional fees of $669,400, and depreciation of $13,651. For the three months ended September 30, 2026, the net loss was $1,391,131, or $(0.07) per basic and diluted share, on a weighted average share count of 20,216,603. The filing notes the company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.

What Was Disclosed

Jaguar Uranium Corp. disclosed unaudited interim financial statements for the quarter and nine months ended September 30, 2026, showing a $22.1 million nine-month net loss largely attributable to listing-related charges, a material increase in total assets following its IPO, and no revenue in any period presented.